Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...
Complete rather than culprit-only revascularization appears to pay off long-term for patients with multivessel disease presenting with non-ST-segment elevation MI (NSTEMI), suggests an observational ...
The vast majority of patients presenting with type 1 NSTEMI undergo invasive coronary angiography in the US, with most receiving PCI, according to an analysis presented this week at CRT 2026. But as ...
Heart attack death rates rose by 1.2% among adults younger than age 55 who were hospitalized between 2011 and 2022 with a first severe heart attack, according to a February study published in the ...
In patients with ST-elevation myocardial infarction (STEMI) and multivessel disease, fractional flow reserve (FFR)-guided complete nonculprit revascularization did not reduce death, myocardial ...
Some clinicians say that testing for occlusion myocardial infarction (OMI) instead might be a better tool for making that determination. “We think we should get rid of the term ST-elevation MI, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results